Nusinersen is a safe and effective treatment for SMA patients of all ages [81]
Typical stacking protocols run both peptides concurrently during the same 10 to 20 day cycle, with thymalin administered at 5 to 10 mg daily via intramuscular or subcutaneous injection
In patients with major burns, trauma, denervation injuries, prolonged immobilization, or other conditions associated with upregulation of immature extrajunctional acetylcholine receptors, receptor activation produces excessive potassium efflux and can precipitate severe hyperkalemia
BermanRMCappielloAAnandAOrenDAHeningerGRCharneyDSet al
Tirzepatide may be considered for its approved metabolic indications in these patients, but it should not replace or delay established autoimmune disease treatments
Omega-3 fatty acids and curcumin provide additional anti-inflammatory support